Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 104
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
NGS detection of gene rearrangements and METexon14 mutations in liquid biopsy of advanced NSCLC patients: A study of two Italian centers 2024 Andrea Boscolo BragadinGiulia PaselloElisabetta ZulatoLaura BonannoStefano Indraccolo + THE JOURNAL OF LIQUID BIOPSY - -
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis 2024 Bonanno, LauraDal Maso, AlessandroPavan, AlbertoPasello, GiuliaGuarneri, Valentina + FRONTIERS IN IMMUNOLOGY - -
Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC 2024 Bonanno, Laura + TARGETED ONCOLOGY - -
Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports 2024 Boscolo Bragadin, AndreaGuarneri, ValentinaBonanno, LauraIndraccolo, Stefano + FRONTIERS IN ONCOLOGY - -
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting 2024 Bonanno, LauraZingone, FabianaBarberio, BrigidaDal Maso, AlessandroPasello, GiuliaDei Tos, Angelo PaoloFassan, MatteoSavarino, Edoardo VincenzoGuarneri, Valentina + THE ONCOLOGIST - -
Clinical evidence and adverse event management update of patients with RET- rearranged advanced non-small-cell lung cancer (NSCLC) treated with pralsetinib 2024 Bonanno, Laura + CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - -
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients 2024 Pasello, GiuliaSalizzato, ValentinaPiccin, LuisaBonanno, LauraGuarneri, Valentina + JOURNAL OF TRANSLATIONAL MEDICINE - -
The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies 2024 Marinato, Gian MarcoPasello, GiuliaGuarneri, ValentinaBonanno, Laura + CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY - -
Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients 2024 Bonanno, LauraDal Maso, AlessandroGuarneri, ValentinaPasello, Giulia + FRONTIERS IN IMMUNOLOGY - -
Secondary prevention and treatment innovation of early stage non-small cell lung cancer: Impact on diagnostic-therapeutic pathway from a multidisciplinary perspective 2023 Pasello, GiuliaBonanno, LauraDell'Amore, AndreaTinè, MariaenricaCalabrese, FiorellaMilella, MicheleRea, FedericoGuarneri, Valentina + CANCER TREATMENT REVIEWS - -
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial 2023 Bonanno, Laura + THE LANCET. RESPIRATORY MEDICINE - -
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non???Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial 2023 Laura Bonanno + JOURNAL OF CLINICAL ONCOLOGY - -
Diagnostic-Therapeutic Pathway and Outcomes of Early Stage NSCLC: a Focus on EGFR Testing in the Real-World 2022 Pasello GLorenzi MPretelli GComacchio GMPezzuto FSchiavon MBuja ABonanno LGuarneri VCalabrese FRea F + FRONTIERS IN ONCOLOGY - -
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg? 2022 Bonanno, LauraDal Maso, AlessandroZulato, ElisabettaPasello, GiuliaGuarneri, ValentinaConte, PierFrancoIndraccolo, Stefano + BRITISH JOURNAL OF CANCER - -
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors 2022 Del Bianco, PaolaBoscolo Bragadin, AndreaMarra, LudovicaPasello, GiuliaFassan, MatteoCalabrese, FiorellaGuarneri, ValentinaConte, Pier FrancoIndraccolo, StefanoBonanno, Laura + BRITISH JOURNAL OF CANCER - -
Circulating cytokines as predictors of response to immune checkpoint inhibitors (ICIs) in patients (pts) with melanoma (Mel) and non–small cell lung cancer (NSCLC) 2022 Pasello, GiuliaFabricio, Aline Sueli CoelhoDel Bianco, PaolaSalizzato, ValentinaPiccin, LuisaBenetti, BeatriceBonanno, LauraGuarneri, ValentinaDe Salvo, Gian LucaChiarion-Sileni, Vanna + JOURNAL OF CLINICAL ONCOLOGY - -
Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP) 2022 Bonanno, Laura + LUNG CANCER - -
Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial 2022 Bonanno, Laura + JOURNAL OF THORACIC ONCOLOGY - -
Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor???Mutated Non???Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial 2022 Laura Bonanno + CLINICAL CANCER RESEARCH - -
Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With Outcome 2022 Pavan, AlbertoFortarezza, FrancescoSchiavon, MarcoEvangelista, LauraPezzuto, FedericaLunardi, FrancescaBonanno, LauraRea, FedericoGuarneri, ValentinaConte, PierFrancoCalabrese, FiorellaPasello, Giulia + THE ONCOLOGIST - -
Mostrati risultati da 1 a 20 di 104
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile